Interview with Leigh Berryman , Chief Executive Officer, Maccine
Which previous professional experiences have led you to join Maccine? Getting my own company to go public in 2006 in Canada was a success for me; the company had grown…
Address: 10 Science Park Road 01-05 The Alpha Singapore Science Park II Singapore 117684,Singapore
Tel: +65 6622 9540
Web: http://www.maccine.com/index.php
Maccine is an established preclinical contract research organization providing innovative discovery support and regulatory safety assessment services.
Operating on a collaborative partnering model, Maccine has developed a portfolio of in vivo assays in key therapeutic areas including Neurology, Psychiatry, Metabolic Disorders, Pain & Inflammation, Oncology, Musculoskeletal Disorders and Women’s Health.
Naturalistic models, clinical biomarkers and clinical technology platforms are employed to better represent the clinical disease state. The team is supported by significant investment in high-end technology and access to a world class scientific community.
Preclinical Contract Research
Which previous professional experiences have led you to join Maccine? Getting my own company to go public in 2006 in Canada was a success for me; the company had grown…
Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear correlation between an inclusive culture and innovation Creating a…
Claus Zieler discusses the Asia Pacific region’s importance to Bayer’s global operations, the company’s commitment to increasing its portfolio of innovative medicines, and the potential for innovation coming from Asian…
As a strong advocate for APAC, Roche Diagnostics’ Managing Director for Asia Pacific, Lance Little, shares his insights on the nuances of the markets in the region, the value proposition…
GEA, a global leader in pharma manufacturing solutions, has recently implemented a successful reorganization to increase their country-level presence both globally and across the Asia-Pacific region with the objective to…
Callum Bir explains Microsoft’s vision and strategy for leveraging the transformative power of technology in healthcare, particularly in terms of its world-leading capabilities in Artificial Intelligence. While Microsoft is ubiquitous, our…
According to A.T. Kearney Health Practice Partner Keith Lostaglio, Southeast Asia presents a significant growth opportunity to the pharma industry, and companies which develop effective digital platforms first will gain…
Frederik Beelaerts van Blokland, Panalpina’s regional head of marketing and sales for Asia Pacific, explains how the company’s focus on the Asia Pacific region is a key growth driver and…
Pierre Fabre Medicament’s MD for Asia Pacific, Ng Tian Wee, on the growing importance of the region for PF, the significance of choosing Singapore as a regional hub, and the…
Coming from DHL’s Customer Solutions & Innovation division, Leonora Lim, Vice President Life Sciences & Healthcare Asia Pacific, gives an insight into the increasingly demanding logistics needs of pharmaceutical clients…
Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and smart investment in infrastructure has helped make the Lion City an indisputable global…
Ong Wee Min, Executive Director of Sales, highlights why Marina Bay Sands is the venue of choice for many international and regional healthcare conferences, the importance of being a true…
Christopher Snook discusses his dual role as Head of Group Country Management as well as Country President for Singapore, highlighting the importance of adhering to in-house as well as country-specific…
See our Cookie Privacy Policy Here
